compounded semaglutide for diabetes (GLP-1) FDA alerts health care providers,

Baar MP, Brandt RM, Putavet DA, Klein JD, Derks KW, Bourgeois BR, et al

(4) Emanuele Montomoli, Simona Piccirella, Baharak Khadang, Elisa Mennitto, Roberto Camerini, and Alfonso De Rosa (2011) Current adjuvants and new perspectives in vaccine formulation Expert Review of Vaccines, 2011 Jul, Volume 10 (Issue 7), Pages 1053-61

While the researchers in the retatrutide study did their best to compare similar studies, they couldn't account for all differences

licensing pattern that has become the dominant path for Chinese incretin assets to reach global markets - and given the depth of the Chinese preclinical long tail documented in Section 3.5, it is likely the template for multiple additional deals in 2026-2027

Agrawal M, Pradhan M, Singhvi G, Patel R, Alexander A, Alexander A